Moderna vs Stryker

Moderna (MRNA), health care, and Stryker (SYK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Stryker is worth $120.2B on the stock market and Moderna $84B: Stryker is valued at 43% more. Moderna's operating margin in its latest fiscal year was -158% and Stryker's 19.5%. Over the past year Moderna's share price has moved +764% and Stryker's -13.6%.

Key facts

Moderna market value
$84B
Stryker market value
$120.2B
Stryker P/E
33.6
Moderna revenue
$1.9BFY to 2025-12-31
Stryker revenue
$25.1BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Moderna vs Stryker: every measure side by side
Measure Moderna Stryker
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$84Blower$120.2Bhigher
Revenue$1.9Blower$25.1Bhigher
Earnings-$2.8Blower$3.2Bhigher
Employees4,700lower56,000higher
Total assets$12.3Blower$47.8Bhigher
Valuation
P/E—33.6
P/S43.2higher4.8lower
P/B12.3higher5.1lower
Dividend yield0.00%lower1.13%higher
Profitability
Operating margin-158%lower19.5%higher
Balance sheet
Net assets$8.7Blower$22.4Bhigher
Total liabilities$3.7Blower$25.4Bhigher
Total debt$590Mlower$15.9Bhigher
Cash on hand$2.6Blower$4Bhigher
Price change
Today-3.57%lower+1.64%higher
1 year+764%higher-13.6%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Moderna only (2)

Percentages are each holding's share of that investor's reported portfolio. Who owns MRNA · Who owns SYK

Further comparisons

Learn

Questions and answers

Which is bigger, Moderna or Stryker?

By market value, Stryker is the larger: $120.2B against $84B for Moderna. By revenue in its latest fiscal year, Stryker is the larger: $25.1B against $1.9B for Moderna.

Which has the higher operating margin?

Stryker: 19.5%, against -158% for Moderna. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Stryker: 1.13%, against 0.00% for Moderna. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Stryker: $15.9B, against $590M for Moderna. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Moderna and Stryker?

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold Moderna and 8 hold Stryker.

Cite this page

Funkfolio, “Moderna vs Stryker”, data as of 17 November 2026. https://funkfolio.com/compare/mrna-vs-syk

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.